Abstract
Unless the federal government changes the course of our medicines policy with intention, Australia's pricing of patented pharmaceuticals is likely to follow inequitable US trends.
Original language | English |
---|---|
Pages (from-to) | 240-242 |
Number of pages | 3 |
Journal | Medical Journal of Australia |
Volume | 187 |
Issue number | 4 |
DOIs | |
Publication status | Published - 20 Aug 2007 |